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Summary Background: Obesity, hyperlipemia and cardiovascular complications
contribute to a significant proportion of morbidity and mortality of renal transplant
patients and have negative effects on renal survival. Aim of the present study was to
evaluate the main abnormalities in body composition and the prevalence of some
cardiovascular risk factors in a population of hemodialyzed (HD) patients awaiting
renal transplantation.
Methods: We studied 151 HD patients, all included in a waiting list for renal
transplantation, 97 males and 54 females, with mean age 47.4712 years. Patients
were divided into three groups according to their body mass index (BMI) (kg/m2): 18.5
to 24.9 (normoweight, NW); 25.0 to 29.9 (overweight, OW); X30 (obese, OB). The
body composition measurements were obtained the day after the mid-week HD
session using bioelectrical impedance analysis (BIA).
Results: We found that 47 patients were NW (31%), while 56 were OW (37%), and 48
were OB (32%). BIA-measured body cell mass was (BCM) significantly increased in the
OW as compared with the NW group (Po0:001), but, of note, no significant difference
was found in OB group in comparison with the OW. Total cholesterol and triglycerides
plasma levels were significantly elevated in OW and OB patients with respect to NW
(Po0:05) and an increased prevalence of diabetes was seen in OB patients (NW: 6%,
OW: 5%, OB: 12%).
Conclusions: These data show that a large proportion of patients awaiting renal
transplant are overweight or obese and a consistent part of them have other
cardiovascular risk factors associated. Furthermore, obese HD patients have a BCM
lower than predicted on the basis of BMI and show an altered metabolic profile. A
better understanding of the characteristics of patients included in the renal
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transplant waiting list is crucial in order to design prospective studies that aim to
define the proper risk profile for the selection of patients.
& 2003 Elsevier Ltd. All rights reserved.
Introduction
Recent data show better survival in overweight and
obese patients undergoing maintenance hemodia-
lyisis therapy, as compared to normal and under-
weight patients. The survival advantage of being
overweight, in hemodialysis patients is in contrast
with the general population where overweight is
accompanied with higher mortality rate. Also other
traditional mortality risk factors, such as total
cholesterol and hypertension, have shown a para-
doxical behavior in hemodialysis patients. Recently,
Cheung et al.1 suggested that hypercholesterole-
mia and hypertension do not bear the cardiovas-
cular disease in chronic hemodialysis patients as
they do in the general population.
In contrast, in transplanted patients obesity,
hyperlipemia and cardiovascular complications
contribute to a significant proportion of morbidity
and mortality and have negative impact on renal
survival.2 Pre-operative obesity has been reported
to worsen the outcome of organ transplantation.
Impairment of graft function as well as decreased
patient and graft survival are associated with high
BMI.3 Metabolic factors also play an important role
in the early or late graft loss after kidney
transplantation. Low levels of serum cholesterol,
triglycerides, and glucose, before and after trans-
plantation, are accompanied by a prolonged graft
survival; prognostic factors for early graft failure
included serum triglycerides4300mg/dl, choles-
terol4250mg/dl before transplantation.4 Lower
systolic and, particularly, lower diastolic blood
pressure values are accompanied by prolonged
graft function.4 Additionally, a history of cigarette
smoking has detrimental effects on graft survival
and correlates with decreased patient survival
after transplantation.5 These aspects should be
emphasized in patients with end-stage renal dis-
ease who are considered for renal transplantation.
Outcome differences in obese and non-obese
renal transplant patients are primarily due to a
higher mortality from cardiac events,6 therefore
appropriate patient selection is crucial to the
success of kidney transplantation.
No studies are available about the prevalence
of Framingham mortality risk factors, such as
hypertension, smoke habit, lipids, body weight
and body mass index in a population of hemodia-
lyisis patients included in a waiting list for renal
transplantation. Furthermore, there are no data
concerning the body composition and the nutri-
tional status of patients candidates to renal
transplant. Aim of the present study was to
evaluate the main abnormalities in body composi-
tion and the prevalence of some traditional risk
factors for cardiovascular disease and their rela-
tionships to body mass index and food intake in a
representative population of hemodialyzed pre-
transplant patients.
Methods
Subjects
This investigation was carried out in 151 patients
included in the waiting list for renal transplant at
the Transplantation Center of the University of
Naples ‘‘Federico II’’, Italy, during the year 2001.
Patients were first screened by the nephrologists of
their dialysis unit and then evaluated by the
transplantation team that followed the general
clinical practice guidelines for the evaluation of
renal transplant candidates.7 The present study
was then performed in all the hemodialysis patients
included in the renal transplant active waiting list.
Patients had the following characteristics: stable
clinical conditions; absence of infections or of any
acute illness in the last 3 months; constancy, for the
last 3 months, of dialysis dose with the same
treatment modality, of dietary intakes, body
weight and routine laboratory measurements.
Adult hemodialysis patients, 96 males and 54
females, with a mean age 47712 years and a BMI
(kg/m2) within the 19–56 range were studied. All
the subjects gave their informed consent to the
study that was approved by the Ethical Committee
of the Medical School of the University Federico II
of Naples. Anthropometric measurements included
body weight (BW) and height (H). Body mass index,
that is considered a reliable parameter to estimate
obesity as risk factor,8 was calculated as the ratio
body weight/height2 (in kg/m2);9 ideal body weight
(IBW) was calculated from the Metropolitan Life
Insurance Tables (Metropolitan Life Insurance CO.,
1983). Patients were divided into three groups
according to the value of BMI: 18.5 to 24.9
(normoweight, NW); 25.0 to 29.9 (overweight,
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OW); X30 (obese, OB).10 All patients were follow-
ing a free intake of calories and proteins.
WHO criteria for the diagnosis of diabetes
mellitus were used11 (fasting plasma glucose
X140mg/dl). Only five patients had border-line
plasma glucose levels and did not receive any
treatment, all other patients that met the diag-
nostic criteria were treated with insulin.
To exclude major alterations of hydration status,
the optimal dry weight was accurately achieved
in each patient according to bioelectrical impe-
dance analysis (BIA) measurements and clinical
criteria: lowest weight at the end of HD session that
the patient can tolerate without intradialytic
symptoms (dizziness, cramps) and hypotension;
absence of peripheral or pulmonary edema.12 In
order to minimize any distortion in BIA measures
caused by fluid excess, patients were studied in the
mid-week interval, the morning after the second
hemodialysis session of the week (Wednesday or
Thursday).
Patients were dialyzed for a mean of 240min
thrice weekly using cellulose modified membranes
with surface area of 1.3–1.6m2, the vascular access
was a native arterio-venous fistula in all of them.
Blood and dialysate flow rates were 250–300 and
500ml/min, respectively. The dialysis solution was
bicarbonate-buffered, isotonic, with the tempera-
ture constantly kept around 371C.
Usual intake was collected during a personal
interview with an expert renal dietitian using a
detailed food-frequency questionnaire of 130 foods
and beverages.13 Dietary protein intake obtained
with this procedure was expressed in g/kg of ideal
body weight.
Bioelectrical impedance analysis measures
In recent years bioimpedance has been shown as a
valid method to study body composition and
nutritional status in hemodialysis patients.14–17 In
this population, the role of BIA has been validated
in nutritional assessment for the estimation of
BCM.14 In HD patients BIA-derived BCM and TBW
strictly correlate with DEXA-derived BCM and D2O
dilution-measured TBW.14 Furthermore, in these
patients, the extent of FFM and FM assessed by BIA
is comparable with the data obtained by measuring
skinfolds thickness.18,19
BIA measurement was performed by the same
investigators in all subjects. Single-frequency BIA
was determined at 50 kHz and 800 mA (model BIA
101 RJL, Akern, Firenze, Italy) according to the
standard tetrapolar technique; to avoid artefacts,
the electrodes were placed on feet, ankles, hands
and wrists on the side of the body free from the
vascular access.20
The body composition measures were calculated
from BIA measurements (resistance and reactance)
and anthropometric variables (BW and H), using
the software provided by the Akern/RJL Systems,
as previously described.21 This predictive model
allows to calculate total body water (TBW), body
fat-mass (BIA-FM) and fat-free mass (BIA-FFM),
body cell mass (BCM) and extra-cellular water
(ECW).
Biochemical and dialysis data
In all patients, fasting (at least 12 h) blood samples
were drawn before the mid-week dialysis session to
measure hemoglobin, hematocrit (Ht), and plasma
levels of urea (reported as blood urea nitrogen,
BUN), albumin, creatinine, cholesterol, high-den-
sity lipoprotein cholesterol (HDL-Col) and triglycer-
ides, serum calcium, serum phosphorus. A sample
was also obtained 2min after the end of the same
mid-week dialysis session to measure the BUN
value. Kt=V ; as measure of dialysis dose, was
calculated by the following equation: 22 InðR
0:008 TdÞ þ ð4 3:5RÞ UF/W, where: R¼ BUN
post-HD/BUN pre-HD, Td¼HD time (hours),
UF¼ ultrafiltration volume, W¼ body weight at
end of dialysis session (kg). Kt=V is a dimensionless
measure of dialytic dose, where K is the urea
dialytic clearance (expressed in ml/ml), t is
treatment time (in minutes) and V is the body
volume cleared by urea at a rate K (V approxi-
mately equals total body water, that is, 58% of dry
weight). The protein intake was calculated as
normalized protein catabolic rate referred to the
actual body weight (nPCR g/kg body wt/day), by
means of a formula from Gotch and Sargent23: 2.03
DCþ 0:16; where DC is the change in BUN during
dialysis (DC ¼ C0  Ct; where C0¼ predialysis BUN
and Ct¼postdialysis BUN, mg/ml) that in steady-
state is equal to the interdialytic rise in BUN. This
equation is based on the assumption that C0 is
constant if both urea generation (DC) and dose of
dialysis (Kt=V) remain constant.
Statistical analysis
Values are given as mean7SD. Analysis of variance
and Bonferroni post-hoc test were used for
the comparison among the three different BMI
group. A Po0:05 was considered significant. Pear-
son w2 test was used to compare prevalence among
groups.
ARTICLE IN PRESS
Body composition and cardiovascular risk factors in pretransplant hemodialysis patients 365
Results
Patients included in the study were divided into
three groups on the basis of the BMI value: 47
patients were normoweight (31%), while 56 were
overweight (37%), and 48 were obese (32%).
Body composition data are reported in Table 1.
BCM (kg) was significantly increased in the over-
weight and obese groups in comparison with the
normoweight group (Po0:001), but, of note, no
significant difference was found between the obese
and the overweight groups. In the obese patients
there was a major increase of adipose tissue, as
indicated by the high fat mass and the fractional fat
mass. Interestingly, we observed a parallel increase
of the Phase Angle in overweight (Po0:05) and
obese (Po0:05) male patients as compared with
normoweight.
Table 2 shows the nutritional intake data. In
overweight and obese patients there was an in-
creased intake of calories and proteins with a parallel
increase of animal proteins and phosphate intake.
Table 3 shows dialysis data and biochemical
markers of nutritional status in the three groups
of patients with different BMI. Dialysis age and Kt=V
values were comparable in the three groups. Total
cholesterol and triglicerydes plasma levels were
significantly elevated in overweight and obese
patients with respect to normoweight (Po0:05).
Serum albumin, protein catabolic rate (nPCR),
serum creatinine and hematocrit were comparable
in the three groups, whereas BUN and phosphate
levels were higher in obese patients. These values
are considered in the optimal range for well-
dialyzed patients. The comparison between the
two values of protein intake obtained from dietary
interviews or from the nPCR, measured by urea
kinetic modelling, shows a higher intake from the
data obtained by the dietician. This finding is not
surprising, since the protein intake derived from
the urea kinetic modelling was normalized by the
actual body weight, whereas that derived by the
dietician was divided by the ideal body weight. At
difference with the dietetic interview or the food
records, that obtain information that cover several
days or a week,24 the PCR measurements vary from
one dialysis session to another. For these reasons
we believe that food records or dietary interviews,
made by an expert dietician, are more reliable than
the PCR measurements to determine long-term
dietary protein. Furthermore, few reports describe
an underestimate of PCR as compared to dietary
records of protein intake.25,26
The frequency distribution of diabetes, hyper-
tension and of smoking habit, for BMI categories is
given in Fig. 1. The prevalence of hypertension and
smoking was similar in the three groups, and was
respectively around 50% and 40%, the presence of
diabetes was increased in the obese group even if
not significantly.
Within the groups of BMI, there was a greater
percentage of patients with elevated plasma levels
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Table 1 Anthropometric and bioimpedance analysis (BIA) data in hemodialyzed patients grouped according to
BMI.
Gender NW OW OB
n ¼ 47 n ¼ 56 n ¼ 48
F, 13 M, 34 F, 18 M, 38 F, 23 M, 25
Age (years) 37.779.3 52.9712.5 43.8713.7 46.8711.7 43.7711.3 49.0710.7
BW (kg) 53.575.5 63.577.3 65.275.4n 75.977.5 83.5716.3n,w 95.979.0
IBW (kg) 55.674.9 64.375.5 57.472.9 67.575.0 58.475.5 66.873.9
BMI (kg/m2) 21.671.8 22.771.4 27.571.8n 27.471.6n 35.375.2n,w 34.573.0n,w
Phase Angle (deg) 5.970.8 6.171.1 6.370.9 6.871.4n 6.471.3 6.871.2n
ECW% 46.073.6 46.375.7 44.974.4 42.375.9n 44.675.1 42.674.7n
FFM-BIA (kg) 39.972.3 50.476.3 41.973.6 56.378.8n 48.177.7n,w 64.679.4n,w
FFM-BIA % 75.076.0 78.878.5 64.576.5n 74.876.0n 57.476.0n,w 66.374.7n,w
FM-BIA (kg) 13.674.3 13.175.3 23.475.5n 18.874.4n 33.979.5n,w 32.475.7n,w
FM-BIA % 24.976.0 20.477.3 35.576.5n 24.475.3n 42.075.2n,w 33.774.7n,w
BCM-BIA (kg) 21.373.4 25.876.1 23.975.3 31.876.9n 28.478.4n 33.774.7n
BCM-BIA % 40.579.4 41.779.3 37.9710.8 41.978.4 35.676.9 35.877.8n,w
IDWG (% BW) 2.570.8 3.370.7 2.970.6 3.170.9 3.770.8n,w 3.971.3w
NW, normoweight; OW, overweight; OB, obese; F, female; M, male; BW, body weight; IBW. ideal body weight; BMI, body mass
index; ECW, extra-cellular water; FFM, fat-free mass; FM, fat mass; BCM, body cell mass, IDWG, inter-dialysis weight gain.
nPo0:05 vs. NW.
wPo0:05 vs. OW.
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of total cholesterol (X240mg/dl) and triglycerides
(X200mg/dl), with a significant trend only for the
triglycerides (Fig. 2).
Of the 151 patients screened, 9% (6F and 8M) had
elevated total cholesterol (X240mg/dl), 10% (4F
and 11M) had low high-density lipoprotein choles-
terol (HDL-Col) levels (o45mg/dl), 39% (18F and
41M) had elevated triglycerides (X200mg/dl), 9%
(5F and 8M) had both elevated total cholesterol and
elevated triglycerides, and 48% were hypertensive
(systolic blood pressure 140 and/ or diastolic blood
pressureX90mmHg or under hypertensive medica-
tion); 34% were smokers, 8.4% were diabetic on
insulin treatment.
Discussion
Renal transplantation is nowadays widely recog-
nized as the treatment of choice for end-stage
renal disease. Transplanted patients, in fact, have
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Table 2 Mean dietary intake based on interviewer-administered questionnaire in hemodialyzed patients grouped
according to BMI.
NW OW OB
n ¼ 47 n ¼ 56 n ¼ 48
Energy (kcal/kgn) 34.779.1 36.878.9 41.479.7w,z
Total protein (g/kgn) 1.2670.3 1.3670.3 1.6170.4w,z
Animal, % total protein 56.179.3 55.577.3 58.7713.2
Total protein, % energy 14.672.3 14.571.6 15.672.2w
Total carbohydrate, % energy 51.075.0 50.675.9 49.178.1
Total fat, % energy 31.974.9 32.175.6 32.177.1
Saturated fat % energy 8.371.8 8.271.4 8.972.9
Polyunsatured fat % energy 2.771.3 2.670.9 2.6871.2
Dietary fiber (g/day) 19.675.3 20.676.1 22.876.3w
Calcium (mg/day) 6417211 7167312 8257335w
Phosphorus (mg/day) 11257327 12407411 13557341w
Alcohol, % energy 2.774.1 2.573.5 3.775.4
NW, normoweight; OW, overweight; OB, obese.
nkg, ideal weight.
wPo0:05 vs. NW.
zPo0:05 vs. OW.
Table 3 Dialysis, biochemical and nutritional data in hemodialyzed patients (n ¼ 151) grouped according to BMI.
NW OW OB
n ¼ 47 n ¼ 56 n ¼ 48
Kt=V 1.070.2 1.170.3 1.170.3
Dialysis age (months) 43725 37724 38723
BUN (mg/dl) 76.3723.3 82.6715.8 87.7719.3n
Hematocrit (%) 33.673.5 32.872.9 32.473.4
Creatinine (mg/dl) 10.472.9 10.372.4 11.072.2
Albumin (g/dl) 4.070.3 3.970.3 3.970.4
NPCR (g/kg/day) 1.170.3 1.270.3 1.270.4
Total cholesterol (mg/dl) 165.1742.9 183.3745.1n 203.9744.8n,w
HDL-Cholesterol (mg/dl) 41.376.7 40.777.4n 38.078.8n
Triglycerides (mg/dl) 165.57109.7 225.67143.3 301.67178.5n,w
Calcium (mg/dl) 9.470.9 9.470.8 9.470.7
Phosphorus (mg/dl) 5.171.5 5.971.7n 5.871.5
Calcium phosphorus 50.4716.3 55.9717.6 55.6716.8
NW, normoweight; OW, overweight; OB, obese; PCR, protein catabolic rate; BUN, blood urea nitrogen.
nPo0:05 vs. NW.
wPo0:05 vs. OW.
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a better survival as compared with patients treated
with dialysis or even with those included in a
waiting list for transplantation.27 A successful
transplant induces a more favorable quality of life
adjustment when compared with other modalities
of treatment of renal failure: hemodialysis and
continuous ambulatory peritoneal dialysis.28 An
appropriate patients selection, however, is a
critical factor for the long-term survival of trans-
planted patients. The present study shows that
a large proportion of patients selected to receive a
renal transplant are overweight or obese and a
consistent part of them have other cardiovascular
risk factors.
The prevalence of obesity is rising to epidemic
proportions around the world at an alarming rate.
This is relatively common in Europe, especially
among women and in Southern and Eastern Eur-
opean countries. Current prevalence data from
individual national studies suggest that the range of
obesity in European countries varies from 10% to
20% for men, and 10% to 25% for women, whereas in
Italy is 9.1% for both men and women and over-
weight prevalence is 48% for men and 25.7% for
women.29 It is of interest that this investigation, in
hemodialysis patients awaiting to be transplanted,
shows a prevalence of obesity (32%) even higher
than that observed in the general population.
These data are in agreement with recent findings,
obtained in the United States, showing that two-
thirds of patients at time of transplantation can be
classified as overweight or obese.30 Several poten-
tial factors may account for this phenomenon: first,
the incident end stage renal disease (ESRD)
population has experienced a similar rising trend
in BMI;31 in fact patients subgroups at increased risk
for chronic kidney disease (e.g., diabetic, blacks,
older) are also those with high prevalence of
obesity. Second, it is very likely that this increase
is only apparent, being the consequence of the
selection criteria used for transplantation with
patients underweight or malnourished being ex-
cluded as candidates for renal transplant.
The BMI distribution in patients evaluated in the
present study is not representative of the entire
ESRD population. In fact, there is a large body of
evidence in the literature that has shown that
uremia and maintenance dialysis itself are powerful
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Figure 2 Percentage of patients with elevated total cholesterol & (X240mg/dl) and elevated triglycerides ’
(X200mg/dl) plasma levels across the BMI categories.
Figure 1 Percentage of diabetic on insulin treatment, smokers and hypertensive patients across BMI categories.
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promoters of protein-energy malnutrition (PEM).
Several studies have shown a different prevalence
of PEM in dialysis population that varies from 26% to
76% of patients, depending on age, comorbidity,
case-mix, or the dose and quality of dialysis
delivered.32,33
Wasting in HD patients may be determined by
multiple factors such as reduced food intake due to
anorexia, hormonal derangement, and altered
protein and energy metabolism that altogether
may induce a hypercatabolic state. Several recent
reports have focused on the association between
malnutrition, inflammation and cardiovascular dis-
ease that are frequently present at the same time
in dialysis patients.34 Measures of PEM and inflam-
mation are major predictors of clinical outcome in
dialysis patients.35,36 A lower protein intake and a
higher prevalence of malnutrition and hypoalbumi-
nemia has been demonstrated in HD patients with
cardiovascular disease (CVD) as compared to
patients without CVD.36,34 Similarly, an elevated
level of serum C-Reactive Protein, a very sensitive
marker of systemic inflammation, or a high produc-
tion of proinflammatory cytokines have been
identified as significant independent predictors of
mortality in dialysis patients.34,37–39 However, it is
not completely clear how cardiac disease, inflam-
mation and PEM in dialysis patients are interre-
lated.40 It has been suggested that inflammation is
the common link among these conditions.36,41–44 In
fact the activation of inflammatory cytokines (IL-6,
TNFa) or their increased release, associated with
uremia or with the dialysis procedure, may induce
anorexia, cause muscle proteolysis and hypoalbu-
minemia, and is involved in the processes that
result in atherosclerotic CVD.34,42,45 This chain of
events, that is primed by proinflammatory cytokines,
has been named by Stenvinkel et al. malnutrition-
inflammation-atherosclerosis (MIA) syndrome.45
Patients with full or partial MIA syndrome under-
going maintenance dialysis, are extremely fragile
and have high mortality rate, therefore it is very
likely that they are not included in the waiting list
for transplantation. This has been partially con-
firmed by a study of demographics of all patients
that received kidney transplant in United States
since 1987,30 that has shown that the proportion of
recipients with lower BMI has fallen by approxi-
mately 50%. This phenomenon may explain the
discrepancy between the BMI distribution observed
in our study and that obtained in the general
hemodialysis population.
BMI has been widely used as a measure for
grading the overweight either in the general
population or in ESRD patients, however, this
parameter cannot differentiate if a weight change
is due to the variation of fat mass, muscle mass or
water. For this reason we performed the analysis of
body composition in our population with the BIA
technique.
When we compared the body composition of
obese with overweight patients, we observed a
significantly increased FM, whereas BCM (kg) was
unchanged (Table 1). In most non-uremic obese
individuals the increment of FM is associated with a
parallel increase of BCM, each change accounting
for almost half of the excess weight;46 similarly,
non-uremic individuals undergoing intentional
overfeeding show a proportional increment of FFM
and FM.47 In a previous study by our group, in older
HD patients, BCM was significantly decreased as
compared to healthy subjects, and in obese
patients BCM was lower than in normoweight HD
patients.48 The increased nutrient intake observed
in HD obese patients (Table 2) was not associated
with a significant change in BCM (Table 1), but
correlated only with the increased FM. Previous
studies have shown that pre-dialysis patients have
significantly higher BCM and FFM as compared with
hemodialysis and transplant patients49 and that
body FM increases significantly in the first year of
maintenance hemodialysis.50 Survival analyses in
the general population, showed that total mortality
is a linear increasing function of high FM and low
FFM.51 Also in dialysis patients a reduced FFM has
been correlated with high mortality.52 The present
data indicate that HD obese patients show a partial
inability to form body cell mass. It is interesting to
note that also the excessive adipose tissue may be a
site of production of inflammatory cytokines (IL-6,
TNFa), this may explain the impaired accrual of
BCM in obese HD patients.53,54 Another possible
explanation for this phenomenon may be the
inadequate physical activity, which is very common
in dialysis patients55 and is eventually more marked
in obese HD patients. Inactivity may exert a greater
influence on protein metabolism and muscle atro-
phy in uremic patients as compared to subjects
with normal renal function.
Nutritional intake, on the average, was adequate
or high in all three groups studied, according
to current guidelines for nutrition in dialysis
patients.56 However, although food intake (i.e.,
energy, total protein, carbohydrate, fat and phos-
phorus) was high in obese patients, with a protein
intake of 1.6 g/kg/IBW (Table 2), this did not seem
to be influential on body composition or serum
albumin of obese patients when compared with the
other groups studied. Furthermore, the high food
intake resulted in an altered lipid profile (lower
plasma HDL-cholesterol, significantly increased
total cholesterol and triglycerides), a greater
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prevalence of diabetes and increased phosphate
plasma levels (Figs. 1 and 2). Block et al. have
recently highlighted the role of hyperphosphatemia
as a risk factor for tissue calcification and increased
cardiovascular mortality in HD patients.57
Several studies have shown a significant inverse
relationship between mortality risk and BMI in HD
populations.58,59 The explanation for this marked
difference in mortality risk related to BMI in HD
population versus the general population is not
known. Our data demonstrate that the increased
body weight in obese patients is mainly due to FM
accrual, suggesting that some of the benefits of
high BMI in HD patients may be due to the increased
energy reserve. This energy availability associated
with the high protein intake observed in these
patients may represent a defense for obese HD
patients against the catabolic insults that they have
to face and may explain their survival advantage.
In contrast with previous studies that have shown
that being obese has a detrimental effect on both
patient and allograft outcome, a recent investiga-
tion has indicated60 that when patients with
significant cardiovascular disease are excluded by
careful screening, obese renal transplant patients
reach long-term survivals that are comparable with
their non obese counterparts. Furthermore, Glan-
ton et al.61 have recently shown that obese
patients on the renal transplant waiting list have
a lower risk of mortality after renal transplantation
compared with those remaining on dialysis. This
survival benefit of renal transplantation did not
apply to patients with BMIX41 kg/m2. These results
confirm that cardiovascular disease is the most
common cause of death in obese ESRD patients,
with a rate of cardiovascular death among patients
remaining on the waiting list that is higher than
that of the kidney transplant recipients. In order to
define the proper risk profile of the obese renal
transplant recipient, future studies are needed to
evaluate the long-term survival for different sub-
groups of obese patients (e.g., moderate versus
severe obesity, different type or degree of comorb-
ities associated with obesity).
This study demonstrates that the majority of
patients included in the waiting list for renal
transplant are overweight or obese and have other
cardiovascular risk factors associated. However,
since after renal transplantation, patients are
exposed to an increasing number of risk factors
such as further gain in adiposity, a worsening lipid
profile, higher risk for diabetes and hypertension, it
seems wise to undertake all the preventive
strategies that would ameliorate the life expec-
tancy of both: patients undergoing renal transplant
and patients remaining on HD treatment. This
approach would include the correction of the
metabolic abnormalities, avoid smoking, increase
physical activity, and obtain a strict control of
diabetes.
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